GSK | Powerful Move Going Into 2026 | LONGGSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three prod
0.49 USD
2.92 B USD
35.61 B USD
About GSK plc
Sector
Industry
CEO
Emma N. Walmsley
Website
Headquarters
London
ISIN
ARDEUT110483
FIGI
BBG003641Z45
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Related stocks
GSK 1-2 wk swing IdeaNYSE:GSK  has set of a daily trigger with a 5/10 ema crossover after a positive earnings report.
During my planning for this idea, I needed to zoom WAY out to the monthly chart in order to understand these levels a bit more. Screen shot of the monthly below:
  
It turns out that last week's close
GSK (GSK) Outperformed  Market ReturnsIn the latest trading session, GSK (GSK) closed at $37.10, marking a +1.23% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Elsewhere, the Dow gained 0.59%, while the tech-heavy Nasdaq added 0.39%.
Prior to today's trading, shares of the dru
Long Glaxo Smith Kline (NAS:GSK) looks very good risk returnUsing longer term Auction Market Theory to construct longer term meaningful #VolumeProfiles can sometimes provide exceptional risk reward setups.
One has just popped up in GSK according to my read anyway. 
Now price has returned into the longer term Value Area there's a very good chance price will
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
XS86659697
GlaxoSmithKline Capital Plc 4.25% 18-DEC-2045Yield to maturity
5.72%
Maturity date
Dec 18, 2045
XS29462437
GlaxoSmithKline Capital Plc 5.25% 10-APR-2042Yield to maturity
5.61%
Maturity date
Apr 10, 2042
XS35082093
GlaxoSmithKline Capital Plc 6.375% 09-MAR-2039Yield to maturity
5.44%
Maturity date
Mar 9, 2039
GX4C
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043Yield to maturity
5.18%
Maturity date
Mar 18, 2043
XS217060907
GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035Yield to maturity
4.99%
Maturity date
May 12, 2035
US377372AE7
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038Yield to maturity
4.92%
Maturity date
May 15, 2038
US377372AQ0
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035Yield to maturity
4.61%
Maturity date
Apr 15, 2035
XS14051686
GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033Yield to maturity
4.55%
Maturity date
Dec 19, 2033
US377372AB3
GlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034Yield to maturity
4.46%
Maturity date
Apr 15, 2034
XS86658852
GlaxoSmithKline Capital Plc 3.375% 20-DEC-2027Yield to maturity
4.11%
Maturity date
Dec 20, 2027
US377372AP2
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030Yield to maturity
4.06%
Maturity date
Apr 15, 2030
See all GSKC bonds
Curated watchlists where GSKC is featured.

Female-led stocks: Who rules the world?
 34  No. of Symbols 

UK stocks: Best of British
 28  No. of Symbols 
See all sparks









